Sun Pharmaceutical (SUNPHARMA) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

Sun Pharmaceutical's Board approved the re-appointment of Dr. Pawan Goenka as Non-Executive Independent Director for a second five-year term from 21 May 2026 to 20 May 2031, subject to shareholder approval. He will continue as Lead Independent Director. Simultaneously, the Board noted the retirement of Ms. Rama Bijapurkar upon completing her first term on 20 May 2026, acknowledging her valuable contributions. Both changes are routine governance matters requiring regulatory disclosure.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

Sun Pharmaceutical reported Q3 FY2025-26 consolidated revenue of ₹154,691 million (up 15.1% YoY) with net profit of ₹33,688 million (up 16.0% YoY). The Board approved an interim dividend of ₹11 per share. Exceptional charges included ₹2,876.4 million for SCD-044 drug discontinuation, ₹3,755.3 million for new labour code compliance, and USD 12.8 million settlement of litigation. Nine-month consolidated sales reached ₹436,604 million (up 11.3% YoY). The company maintains India's No. 1 pharma position with 8.4% market share and 5.8% R&D intensity.

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this board meeting affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 31 January 2026?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 31 January 2026

WIPRO Wipro Limited Corporate Action AMBUJACEM Ambuja Cements Limited Financial Results AMBUJACEM Ambuja Cements Limited Financial Results DELHIVERY Delhivery Limited Financial Results DELHIVERY Delhivery Limited Announcement DELHIVERY Delhivery Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.